379 related articles for article (PubMed ID: 11513182)
1. Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study.
Annese V; Andreoli A; Andriulli A; Dinca R; Gionchetti P; Latiano A; Lombardi G; Piepoli A; Poulain D; Sendid B; Colombel JF
Am J Gastroenterol; 2001 Aug; 96(8):2407-12. PubMed ID: 11513182
[TBL] [Abstract][Full Text] [Related]
2. Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients, their relatives or associated clinical factors.
Hadrich I; Vandewalle P; Cheikhrouhou F; Makni F; Krichen MS; Sendid B; Standaert-Vitse A; Ayadi A; Poulain D
Scand J Gastroenterol; 2007 Jun; 42(6):717-25. PubMed ID: 17505994
[TBL] [Abstract][Full Text] [Related]
3. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
[TBL] [Abstract][Full Text] [Related]
4. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease.
Sendid B; Quinton JF; Charrier G; Goulet O; Cortot A; Grandbastien B; Poulain D; Colombel JF
Am J Gastroenterol; 1998 Aug; 93(8):1306-10. PubMed ID: 9707056
[TBL] [Abstract][Full Text] [Related]
5. Candida albicans colonization and ASCA in familial Crohn's disease.
Standaert-Vitse A; Sendid B; Joossens M; François N; Vandewalle-El Khoury P; Branche J; Van Kruiningen H; Jouault T; Rutgeerts P; Gower-Rousseau C; Libersa C; Neut C; Broly F; Chamaillard M; Vermeire S; Poulain D; Colombel JF
Am J Gastroenterol; 2009 Jul; 104(7):1745-53. PubMed ID: 19471251
[TBL] [Abstract][Full Text] [Related]
6. Serologic testing with ANCA, ASCA, and anti-OmpC in children and young adults with Crohn's disease and ulcerative colitis: diagnostic value and correlation with disease phenotype.
Zholudev A; Zurakowski D; Young W; Leichtner A; Bousvaros A
Am J Gastroenterol; 2004 Nov; 99(11):2235-41. PubMed ID: 15555007
[TBL] [Abstract][Full Text] [Related]
7. Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's disease.
Mei L; Targan SR; Landers CJ; Dutridge D; Ippoliti A; Vasiliauskas EA; Papadakis KA; Fleshner PR; Rotter JI; Yang H
Gastroenterology; 2006 Apr; 130(4):1078-85. PubMed ID: 16618402
[TBL] [Abstract][Full Text] [Related]
8. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease.
Koutroubakis IE; Petinaki E; Mouzas IA; Vlachonikolis IG; Anagnostopoulou E; Castanas E; Maniatis AN; Kouroumalis EA
Am J Gastroenterol; 2001 Feb; 96(2):449-54. PubMed ID: 11232689
[TBL] [Abstract][Full Text] [Related]
9. Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases.
Bartůnková J; Kolárová I; Sedivá A; Hölzelová E
Clin Immunol; 2002 Feb; 102(2):162-8. PubMed ID: 11846458
[TBL] [Abstract][Full Text] [Related]
10. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease--an IG-IBD study.
Annese V; Lombardi G; Perri F; D'Incà R; Ardizzone S; Riegler G; Giaccari S; Vecchi M; Castiglione F; Gionchetti P; Cocchiara E; Vigneri S; Latiano A; Palmieri O; Andriulli A
Am J Gastroenterol; 2005 Jan; 100(1):84-92. PubMed ID: 15654786
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases].
Mokrowiecka A; Gasiorowska A; Małecka-Panas E
Pol Merkur Lekarski; 2004; 17 Suppl 1():22-6. PubMed ID: 15603341
[TBL] [Abstract][Full Text] [Related]
12. [Interest of serologic markers in inflammatory bowel disease. About 105 cases].
Fekih M; Ben Hlima S; Zitouni M; Matri S; Boubaker J; Makni S; Azza F
Tunis Med; 2007 Oct; 85(10):821-8. PubMed ID: 18236802
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
[TBL] [Abstract][Full Text] [Related]
14. Detection of antisynthetic mannoside antibodies (ASigmaMA) reveals heterogeneity in the ASCA response of Crohn's disease patients and contributes to differential diagnosis, stratification, and prediction.
Vandewalle-El Khoury P; Colombel JF; Joossens S; Standaert-Vitse A; Collot M; Halfvarson J; Ayadi A; Landers CJ; Vermeire S; Rutgeerts P; Targan SR; Chamaillard M; Mallet JM; Sendid B; Poulain D
Am J Gastroenterol; 2008 Apr; 103(4):949-57. PubMed ID: 18047546
[TBL] [Abstract][Full Text] [Related]
15. Clinical features in familial cases of Crohn's disease and ulcerative colitis in Italy: a GISC study. Italian Study Group for the Disease of Colon and Rectum.
Annese V; Andreoli A; Astegiano M; Campieri M; Caprilli R; Cucchiara S; D'Incà R; Giaccari S; Iaquinto G; Lombardi G; Napolitano G; Pera A; Riegler G; Valpiani D; Andriulli A;
Am J Gastroenterol; 2001 Oct; 96(10):2939-45. PubMed ID: 11693330
[TBL] [Abstract][Full Text] [Related]
16. Low Mannan-binding lectin serum levels are associated with complicated Crohn's disease and reactivity to oligomannan (ASCA).
Schoepfer AM; Flogerzi B; Seibold-Schmid B; Schaffer T; Kun JF; Pittet V; Mueller S; Seibold F
Am J Gastroenterol; 2009 Oct; 104(10):2508-16. PubMed ID: 19532127
[TBL] [Abstract][Full Text] [Related]
17. Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatment.
Teml A; Kratzer V; Schneider B; Lochs H; Norman GL; Gangl A; Vogelsang H; Reinisch W
Am J Gastroenterol; 2003 Oct; 98(10):2226-31. PubMed ID: 14572572
[TBL] [Abstract][Full Text] [Related]
18. Significance of anti-sacharomices cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in Romania.
Preda CM; Diculescu M; Mirea V; Marica C; Vermeire S; Rutgeerts P; Oproiu A
Rom J Gastroenterol; 2005 Mar; 14(1):23-6. PubMed ID: 15800689
[TBL] [Abstract][Full Text] [Related]
19. [p-ANCA and ASCA antibodies in the differential diagnosis between ulcerative rectocolitis and Crohn's disease].
Lecis P; Germanà B; Papa N; Bertiato G; Doglioni C; Galliani E; Biedo FC
Recenti Prog Med; 2002 May; 93(5):308-13. PubMed ID: 12050913
[TBL] [Abstract][Full Text] [Related]
20. [Initial experience with detection of Saccharomyces cerevisiae antibodies in patients with primary nonspecific inflammatory bowel disease].
Malícková K; Janatková I; Fucíková T; Adamec S; Lukás M
Epidemiol Mikrobiol Imunol; 2001 Aug; 50(3):131-5. PubMed ID: 11550421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]